Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Clinical trial NCT01989572 · COMPLETED

Trial details

NCT number: NCT01989572
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Iris Melanoma Medium/Large Size Posterior Uveal Melanoma Mucosal Melanoma Ocular Melanoma With Extraocular Extension Recurrent Melanoma Recurrent Uveal Melanoma Small Size Posterior Uveal Melanoma Stage IIA Cutaneous Melanoma AJCC v6 and v7 Stage IIA Uveal Melanoma AJCC v7 Stage IIB Cutaneous Melanoma AJCC v6 and v7 Stage IIB Uveal Melanoma AJCC v7 Stage IIC Cutaneous Melanoma AJCC v6 and v7

Start date: 2000-02-23
Primary completion: 2012-10-08
Enrollment: 815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.